EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

The circulating tumor microenvironment in small-cell lung cancer: Vimentin-positive circulating tumor endothelial cells as drivers of metastasis and poor prognosis in a large cohort study

Ying Wang, Fei Qi, Minghang Zhang, Qunhui Wang, Yanxia Liu, Baohua Lu, Yuan Gao, Ruizi Ren, Mingming Hu, Xingsheng Hu, Jingying Nong, Peter Ping Lin und 1 weitere

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218852 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Letters, 2026. Verfasst von Ying Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beiji…. Hauptthemen laut MEDLINE: Vimentin, Tumor Microenvironment, Lung Neoplasms, Neoplastic Cells, Circulating. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aggressive progression of small-cell lung cancer (SCLC) is orchestrated by a dynamic tumor microenvironment (TME). However, profiling this ecosystem remains a major constraint. The critical role of CD31+ aneuploid circulating tumor endothelial cells expressing vimentin (i.e. Vim + CTECs amid Endo-MT process) in promoting SCLC metastasis was systematically investigated in this study. Large cohorts of 142 treatment-naïve SCLC patients were prospectively enrolled in the current multicenter study. Patients were subjected to the first-line platinum-based chemotherapy alone or combined with immunotherapy or radiotherapy as indicated. Both Vim- and Vim + CTECs were longitudinally co-detected at baseline (t0), after two cycles (t1), and post-complete treatment (t2). A high baseline CTEC count (≥15/6 mL) correlated with a higher incidence of liver metastasis and a lower initial disease control rate. Positive detection of Vim+ CTECs (t0) was also significantly associated with liver metastasis. Multivariate analysis identified post-treatment Vim+ CTECs (t1-2) as an independent prognostic factor for both inferior progression-free survival (PFS) and overall survival (OS). The metastasis-promoting function of endothelial vimentin was further validated using in vivo liver metastasis mouse models and in vitro vimentin-knockdown endothelial cell lines. Mechanistically, endothelial vimentin was essential for promoting SCLC cell proliferation, migration, liver metastasis in vivo, and invasion in vitro, which were abrogated by vimentin knockdown. Vim + CTECs serve as a key driver of tumor metastasis in SCLC. Detection of Vim + CTECs constitutes a novel paradigm for real-time risk stratification and outcome prediction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VimentinTumor MicroenvironmentLung NeoplasmsNeoplastic Cells, CirculatingSmall Cell Lung CarcinomaEndothelial CellsLiver NeoplasmsHumansFemaleMalePrognosisAnimalsMiddle AgedAgedBiomarkers, TumorMiceAdult

Stichwörter der Autor:innen

Circulating tumor endothelial cellsCirculating tumor microenvironmentPrognosisSmall cell lung cancerVimentin

Substanzen

VimentinVIM protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Oncology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
  • Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China; Department of Thoracic surgery, Chongqing University Fuling…
  • The First Clinical Medical College of Shaanxi University of Chinese Medicine, Xianyang, China.
  • Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Cytelligen, San Diego, CA, USA.

Förderung

  • Beijing Municipal Science and Technology Commission

Zitieren

APA

Wang, Y., Qi, F., Zhang, M., Wang, Q., Liu, Y., Lu, B., Gao, Y., Ren, R., Hu, M., Hu, X., Nong, J., Lin, P. P., & Zhang, T. (2026). The circulating tumor microenvironment in small-cell lung cancer: Vimentin-positive circulating tumor endothelial cells as drivers of metastasis and poor prognosis in a large cohort study. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218852

Vancouver

Wang Y, Qi F, Zhang M, Wang Q, Liu Y, Lu B, et al. The circulating tumor microenvironment in small-cell lung cancer: Vimentin-positive circulating tumor endothelial cells as drivers of metastasis and poor prognosis in a large cohort study. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218852

BibTeX
@article{Wang2026,
  author = {Wang, Ying and Qi, Fei and Zhang, Minghang and Wang, Qunhui and Liu, Yanxia and Lu, Baohua and Gao, Yuan and Ren, Ruizi and Hu, Mingming and Hu, Xingsheng and Nong, Jingying and Lin, Peter Ping and Zhang, Tongmei},
  title = {The circulating tumor microenvironment in small-cell lung cancer: Vimentin-positive circulating tumor endothelial cells as drivers of metastasis and poor prognosis in a large cohort study},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218852}
}
Kostenlos starten →